Claude Petit
Vice President of Biometrics and Data Management, Boehrigner Ingelheim
Claude joined Boehringer Ingelheim, France as a Biostatistics and Programming Support Head in 2004. Since January 2015, she has been the Vice President of Biostatistics and Data Sciences. She is playing key roles in developing and evaluating long term strategies for the organization including authoring of guidelines and concept papers for efficient processes, training international teams in Americas and China. Recently she is focusing on big data, real world evidence and how the pharmaceutical industry can partner with the US payers. She has been involved in several submissions in Europe and in the US, interacting with the FDA through NDA meetings, Advisory Committees and sponsor audits.
Claude served as Adjunct Professor in Mathematics & Statistics at the University of Grenoble (1999), Medical University of Paris (2004), and at Ecole Nationale de la Statistique et d’Administration Informatique (ENSAI), until her arrival in the US in 2007. She has been appointed as lecturer at Yale since July 2012.
She served as Adjunct Professor in Mathematics & Statistics at the University of Grenoble (1999), Medical University of Paris (2004), and at Ecole Nationale de la Statistique et d’Administration Informatique (ENSAI), until her arrival in the US in 2007. She has been appointed as lecturer at Yale since July 2012.
Extensively published, Claude served for many years as Secretary of Biopharmaceutical and Health group in SFdS responsible for the relationships with The French Agency for Sanitary & Safety of Health Products (AFSSAPS). Moreover she has been the Treasurer of the Organizing Committees of the 5th international meeting of SFdS and chaired the Organizing Committee of the 6th international meeting of SFdS (Paris, sept 2009).
She is also a member of several statistical associations as PSI and DIA and thanks to her extensive work as a project statistician in oncology has been accepted as an ASCO member. Her area of interest is the use of Bayesian methods in phase IIb/III trials.
Claude received her Masters’ degree (1993) from one of France’s leading institutions of higher learning in statistics and economics. She earned her PhD, concurrent with a medical degree in 1999 in the field of Biostatistics from the University of Kremlin Bicêtre (France) where she studied under Prof. Jean Maccario, employing Bayesian methods as applied to clinical trials, specifically involving the study and treatment of schizophrenia.